Literature DB >> 2846872

Poliovirus proteinase 3C: large-scale expression, purification, and specific cleavage activity on natural and synthetic substrates in vitro.

M J Nicklin1, K S Harris, P V Pallai, E Wimmer.   

Abstract

Proteinase 3C of poliovirus type 2 (Sabin) was expressed at 4% total protein in Escherichia coli. The protein was soluble and could be purified by a simple scheme. It was weakly active on the capsid precursor P1 (expressed in vitro), which contains two cleavage sites. The products of processing P1 were 1ABC and 1D (VP1). The activity was insensitive to Triton X-100. Crude extracts of cells infected with poliovirus type 1 (Mahoney) gave strong processing and yielded 1AB (VP0), 1C (VP3), and 1D in the same assay system but were sensitive to detergent. 3C from cell extracts that was separated from its precursors resembled the recombinant proteinase in its activity. Recombinant 3C cleaved the peptide dansyl-Glu-Glu-Glu-Ala-Met-Glu-Gln-Gly-Ile-Thr-Asn-Lys-NH2 at the Gln-Gly bond. We conclude that 3C is merely the core of the Gln-Gly-cleaving activity which processes P1 in vivo and that there is probably a hydrophobic contact between a larger 3C precursor and its P1 substrate which allows the second processing reaction: 1ABC, 1D----1AB, 1C, 1D.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846872      PMCID: PMC254243     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Translation of encephalomyocarditis virus RNA in vitro yields an active proteolytic processing enzyme.

Authors:  H R Pelham
Journal:  Eur J Biochem       Date:  1978-04-17

2.  Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor.

Authors:  M F Ypma-Wong; P G Dewalt; V H Johnson; J G Lamb; B L Semler
Journal:  Virology       Date:  1988-09       Impact factor: 3.616

3.  Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants.

Authors:  H Toyoda; M Kohara; Y Kataoka; T Suganuma; T Omata; N Imura; A Nomoto
Journal:  J Mol Biol       Date:  1984-04-25       Impact factor: 5.469

4.  Primary structure, gene organization and polypeptide expression of poliovirus RNA.

Authors:  N Kitamura; B L Semler; P G Rothberg; G R Larsen; C J Adler; A J Dorner; E A Emini; R Hanecak; J J Lee; S van der Werf; C W Anderson; E Wimmer
Journal:  Nature       Date:  1981-06-18       Impact factor: 49.962

5.  Biochemical evidence for intertypic genetic recombination of polioviruses.

Authors:  L I Romanova; E A Tolskaya; M S Kolesnikova; V I Agol
Journal:  FEBS Lett       Date:  1980-08-25       Impact factor: 4.124

6.  Protein processing map of poliovirus.

Authors:  M A Pallansch; O M Kew; B L Semler; D R Omilianowski; C W Anderson; E Wimmer; R R Rueckert
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

7.  Systematic nomenclature of picornavirus proteins.

Authors:  R R Rueckert; E Wimmer
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

8.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.

Authors:  A J Barrett; A A Kembhavi; M A Brown; H Kirschke; C G Knight; M Tamai; K Hanada
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

9.  Identification of poliovirus polypeptide P63 as a soluble RNA-dependent RNA polymerase.

Authors:  T A Van Dyke; J B Flanegan
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

10.  Evidence for histidine in the active site of papain.

Authors:  S S Husain; G Lowe
Journal:  Biochem J       Date:  1968-08       Impact factor: 3.857

View more
  47 in total

1.  Translation of polioviral mRNA is inhibited by cleavage of polypyrimidine tract-binding proteins executed by polioviral 3C(pro).

Authors:  Sung Hoon Back; Yoon Ki Kim; Woo Jae Kim; Sungchan Cho; Hoe Rang Oh; Jung-Eun Kim; Sung Key Jang
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Intermolecular cleavage of hepatitis A virus (HAV) precursor protein P1-P2 by recombinant HAV proteinase 3C.

Authors:  Y Y Kusov; W Sommergruber; M Schreiber; V Gauss-Müller
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase.

Authors:  K S Harris; S R Reddigari; M J Nicklin; T Hämmerle; E Wimmer
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

4.  Flavivirus enzyme-substrate interactions studied with chimeric proteinases: identification of an intragenic locus important for substrate recognition.

Authors:  F Preugschat; E M Lenches; J H Strauss
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

5.  Role for the P4 amino acid residue in substrate utilization by the poliovirus 3CD proteinase.

Authors:  W S Blair; B L Semler
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

6.  Poliovirus thiol proteinase 3C can utilize a serine nucleophile within the putative catalytic triad.

Authors:  M A Lawson; B L Semler
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

7.  trans rescue of a mutant poliovirus RNA polymerase function.

Authors:  W A Charini; C C Burns; E Ehrenfeld; B L Semler
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

Review 8.  Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.

Authors:  W G Dougherty; B L Semler
Journal:  Microbiol Rev       Date:  1993-12

9.  Degradation of the interferon-induced 68,000-M(r) protein kinase by poliovirus requires RNA.

Authors:  T L Black; G N Barber; M G Katze
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  Substitutions in the protease (3Cpro) gene of poliovirus can suppress a mutation in the 5' noncoding region.

Authors:  R Andino; G E Rieckhof; D Trono; D Baltimore
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.